IMPORTANT: Labor & Delivery services have moved from Temple University Hospital–Main Campus (Broad & Ontario) to our new women & families hospital.

800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids (Umbriel)

view all Clinical Trials

Overview

This is a dose-range finding, double-blind, placebo-controlled, phase IIb study designed to assess efficacy and safety of tozorakimab administered subcutaneously in adult participants with uncontrolled asthma receiving medium-to-high dose inhaled corticosteroids.

Clinical Trial Information

Protocol

TIRB#: 32326

Phase

2

Condition(s)

Asthma

Investigator

Kartik Shenoy, MD

Coordinator

Arwa Mukthar

Visit clinicaltrials.gov for full description.

Contact

For more information about this trial or to inquire about eligibility, email [email protected] or call 215-707-1359.

Full Title

A Phase IIb, Multicentre, Double-blind, Placebo-controlled Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adult Participants With Uncontrolled Asthma on Medium-to High Dose Inhaled Corticosteroids